185 related articles for article (PubMed ID: 20185823)
1. Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.
Qu Z; Fu J; Yan P; Hu J; Cheng SY; Xiao G
J Biol Chem; 2010 Apr; 285(16):11786-92. PubMed ID: 20185823
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic target.
Qu Z; Yan P; Fu J; Jiang J; Grusby MJ; Smithgall TE; Xiao G
Cancer Res; 2010 Mar; 70(5):1766-72. PubMed ID: 20145149
[TBL] [Abstract][Full Text] [Related]
3. Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.
Sun F; Xiao Y; Qu Z
J Biol Chem; 2015 Mar; 290(12):7362-8. PubMed ID: 25681443
[TBL] [Abstract][Full Text] [Related]
4. Human T-cell leukemia virus type I-mediated repression of PDZ-LIM domain-containing protein 2 involves DNA methylation but independent of the viral oncoprotein tax.
Yan P; Qu Z; Ishikawa C; Mori N; Xiao G
Neoplasia; 2009 Oct; 11(10):1036-41. PubMed ID: 19794962
[TBL] [Abstract][Full Text] [Related]
5. PDLIM2 acts as a cancer suppressor gene in non-small cell lung cancer via the down regulation of NF-κB signaling.
Shi H; Ji Y; Li W; Zhong Y; Ming Z
Mol Cell Probes; 2020 Oct; 53():101628. PubMed ID: 32621848
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.
Zhao L; Yu C; Zhou S; Lau WB; Lau B; Luo Z; Lin Q; Yang H; Xuan Y; Yi T; Zhao X; Wei Y
Oncotarget; 2016 Jan; 7(2):1408-20. PubMed ID: 26593252
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.
Yamamoto M; Ito T; Shimizu T; Ishida T; Semba K; Watanabe S; Yamaguchi N; Inoue J
Cancer Sci; 2010 Nov; 101(11):2391-7. PubMed ID: 20735436
[TBL] [Abstract][Full Text] [Related]
9. Kruppel like factor 10 up-regulates PDZ and LIM domain containing protein 2 via nuclear factor kappa-B pathway to inhibit proliferation and inflammatory of fibroblastoid synovial cell in rheumatoid arthritis.
Wang S; Zha X; Ruan S; Yao S; Zhang X
Bioengineered; 2022 Jan; 13(1):1779-1790. PubMed ID: 34713769
[TBL] [Abstract][Full Text] [Related]
10. Role of estrogen receptor gene demethylation and DNA methyltransferase.DNA adduct formation in 5-aza-2'deoxycytidine-induced cytotoxicity in human breast cancer cells.
Ferguson AT; Vertino PM; Spitzner JR; Baylin SB; Muller MT; Davidson NE
J Biol Chem; 1997 Dec; 272(51):32260-6. PubMed ID: 9405430
[TBL] [Abstract][Full Text] [Related]
11. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance.
Sun F; Li L; Yan P; Zhou J; Shapiro SD; Xiao G; Qu Z
Nat Commun; 2019 Nov; 10(1):5324. PubMed ID: 31757943
[TBL] [Abstract][Full Text] [Related]
12. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
[TBL] [Abstract][Full Text] [Related]
13. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit.
Tanaka T; Grusby MJ; Kaisho T
Nat Immunol; 2007 Jun; 8(6):584-91. PubMed ID: 17468759
[TBL] [Abstract][Full Text] [Related]
14. [PDLIM2 and Its Role in Oncogenesis--Tumor Suppressor or Oncoprote?].
Maryáš J; Bouchal P
Klin Onkol; 2015; 28 Suppl 2():2S40-6. PubMed ID: 26374157
[TBL] [Abstract][Full Text] [Related]
15. PDLIM2: Signaling pathways and functions in cancer suppression and host immunity.
Guo ZS; Qu Z
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188630. PubMed ID: 34571051
[TBL] [Abstract][Full Text] [Related]
16. Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB.
Guan H; Mi B; Li Y; Wu W; Tan P; Fang Z; Li J; Zhang Y; Li F
Cell Signal; 2015 May; 27(5):969-77. PubMed ID: 25683916
[TBL] [Abstract][Full Text] [Related]
17. Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
Healy NC; O'Connor R
J Leukoc Biol; 2009 Mar; 85(3):481-90. PubMed ID: 19052146
[TBL] [Abstract][Full Text] [Related]
18. PDLIM7 Synergizes With PDLIM2 and p62/Sqstm1 to Inhibit Inflammatory Signaling by Promoting Degradation of the p65 Subunit of NF-κB.
Jodo A; Shibazaki A; Onuma A; Kaisho T; Tanaka T
Front Immunol; 2020; 11():1559. PubMed ID: 32849529
[TBL] [Abstract][Full Text] [Related]
19. PDLIM2 protects articular chondrocytes from lipopolysaccharide-induced apoptosis, degeneration and inflammatory injury through down-regulation of nuclear factor (NF)-κB signaling.
Guo Q; Xu J; Shi Q; Wu S
Int Immunopharmacol; 2020 Nov; 88():106883. PubMed ID: 32805696
[TBL] [Abstract][Full Text] [Related]
20. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
